AstraZeneca pays $1.24bn for antidepressant drug

Second-biggest British pharma group in deal with US biotech firm Targacept

AstraZeneca is to spend up to $1.24bn on the rights to an experimental antidepressant drug as it expands its pipeline of neuroscience treatments, the group said yesterday.

The Anglo-Swedish group has agreed a deal with US biotech company Targacept for the development of a treatment currently known as TC-5214. AstraZeneca will pay $200m in upfront fees, and $540m as the drug hits regulatory milestones before gaining a licence.

The final tranche, worth $500m to the North Carolina-based group, will be made if sales targets are hit. Targacept is also entitled to royalties on sales under the terms of the deal.

TC-5214 has already negotiated the second phase of trials, with final tests set for the middle of next year. AstraZeneca said yesterday that it hopes to get a licence to launch the drug by 2012, undertaking to pay 80 per cent of the costs associated with getting the treatment to market.

"The deal highlights AstraZeneca's long-term commitment to the depression market and if development is successful should enhance the company's franchise in this key market," said Savvas Neophytou, an analyst at Panmure Gordon. "Depression represents a significant franchise for AstraZeneca, with its depression drug Seroquel accounting for 15 per cent of [estimated] 2009 revenues. If successful this the drug will strengthen the AstraZeneca's depression franchise."

AstraZeneca, the UK's second-biggest pharmaceutical group, believes that the benefits of strengthening its presence in the market for depression drugs are potentially huge. According to the company, 42 million people worldwide suffer from Major Depressive Disorder, the type of the illness that TC-5214 is designed to treat. The worldwide antidepressant market is worth more than $20bn a year to the pharmaceutical industry.

"The opportunity to improve treatment in depression is a large one, both commercially and in terms of benefits for patients," said AstraZeneca's chief executive, David Brennan. "It's an area both AstraZeneca and Targacept know well and I'm pleased to be adding another late-stage project to our pipeline."

Like several large pharmaceutical groups, AstraZeneca is desperate to strengthen its pipeline of drugs as products that have contributed strong profits in the past face greater competition from generic drug makers. Seroquel, which also treats schizophrenia, was AstraZeneca's second-best selling treatment last year, behind Nexium, a heartburn drug.

TC-5214 is a nicotinic channel blocker that works in a different way to most antidepressants. Targacept was spun out of the research arm of RJ Reynolds Tobacco in 2000 and specialises in developing drugs that affect the brain in similar ways to tobacco products.

Arts and Entertainment
Lena Dunham
booksLena Dunham's memoirs - written at the age of 28 - are honest to the point of making you squirm
Arts and Entertainment
A bit rich: Maggie Smith in Downton Abbey
tvDownton Abbey review: It's six months since we last caught up with the Crawley clan
Frank Lampard and his non-celebration
premier leagueManchester City vs Chelsea match report from the Etihad Stadium
Life and Style
A new app has been launched that enables people to have a cuddle from a stranger
techNew app offers 'PG alternative' to dating services like Tinder
Jacqueline Bisset has claimed that young women today are obsessed with being 'hot', rather than 'charming', 'romantic' or 'beautiful'
Arts and Entertainment
Jake Quickenden sings his heart out in his second audition
tvX Factor: How did the Jakes - and Charlie Martinez - fare?
premier league
Arts and Entertainment
'New Tricks' star Dennis Waterman is departing from the show after he completes filming on two more episodes
tvOnly remaining original cast-member to leave crime series
Mario Balotelli celebrates his first Liverpool goal
premier leagueLiverpool striker expressed his opinion about the 5-3 thriller with Leicester - then this happened
ebooksAn unforgettable anthology of contemporary reportage
Britain's shadow chancellor Ed Balls (L) challenges reporter Rob Merrick for the ball during the Labour Party versus the media soccer match,
peopleReporter left bleeding after tackle from shadow Chancellor in annual political football match
Arts and Entertainment
Female fans want more explicit male sex in Game of Thrones, George R R Martin says
tvSpoiler warning: Star of George RR Martin's hit series says viewers have 'not seen the last' of him/her
Plenty to ponder: Amir Khan has had repeated problems with US immigration because of his Muslim faith and now American television may shun him
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Senior BA - Motor and Home Insurance

£400 - £450 Per Day: Clearwater People Solutions Ltd: **URGENT CONTRACT ROLE**...

Market Risk & Control Manager

Up to £100k or £450p/d: Saxton Leigh: My client is a leading commodities tradi...

SQL Developer - Watford/NW London - £320 - £330 p/d - 6 months

£320 - £330 per day: Ashdown Group: The Ashdown Group have been engaged by a l...

Head of Audit

To £75,000 + Pension + Benefits + Bonus: Saxton Leigh: My client is looking f...

Day In a Page

A roller-coaster tale from the 'voice of a generation'

Not That Kind of Girl:

A roller-coaster tale from 'voice of a generation' Lena Dunham
London is not bedlam or a cradle of vice. In fact it, as much as anywhere, deserves independence

London is not bedlam or a cradle of vice

In fact it, as much as anywhere, deserves independence
Vivienne Westwood 'didn’t want' relationship with Malcolm McLaren

Vivienne Westwood 'didn’t want' relationship with McLaren

Designer 'felt pressured' into going out with Sex Pistols manager
Jourdan Dunn: Model mother

Model mother

Jordan Dunn became one of the best-paid models in the world
Apple still coolest brand – despite U2 PR disaster

Apple still the coolest brand

Despite PR disaster of free U2 album
Scottish referendum: The Yes vote was the love that dared speak its name, but it was not to be

Despite the result, this is the end of the status quo

Boyd Tonkin on the fall-out from the Scottish referendum
Manolo Blahnik: The high priest of heels talks flats, Englishness, and why he loves Mary Beard

Manolo Blahnik: Flats, Englishness, and Mary Beard

The shoe designer who has been dubbed 'the patron saint of the stiletto'
The Beatles biographer reveals exclusive original manuscripts of some of the best pop songs ever written

Scrambled eggs and LSD

Behind The Beatles' lyrics - thanks to Hunter Davis's original manuscript copies
'Normcore' fashion: Blending in is the new standing out in latest catwalk non-trend

'Normcore': Blending in is the new standing out

Just when fashion was in grave danger of running out of trends, it only went and invented the non-trend. Rebecca Gonsalves investigates
Dance’s new leading ladies fight back: How female vocalists are now writing their own hits

New leading ladies of dance fight back

How female vocalists are now writing their own hits
Mystery of the Ground Zero wedding photo

A shot in the dark

Mystery of the wedding photo from Ground Zero
His life, the universe and everything

His life, the universe and everything

New biography sheds light on comic genius of Douglas Adams
Save us from small screen superheroes

Save us from small screen superheroes

Shows like Agents of S.H.I.E.L.D are little more than marketing tools
Reach for the skies

Reach for the skies

From pools to football pitches, rooftop living is looking up
These are the 12 best hotel spas in the UK

12 best hotel spas in the UK

Some hotels go all out on facilities; others stand out for the sheer quality of treatments